To assess if the preoperative lymph node invasion (LNI) risk could be used to tailor the extent of pelvic lymph node dissection (PLND) according to individual profile in patients with prostate cancer (PCa) undergoing radical prostatectomy (RP), and to identify those who would benefit from the removal of the common iliac and pre-sacral nodes.
Objectives
To assess if the preoperative lymph node invasion (LNI) risk could be used to tailor the extent of pelvic lymph node dissection (PLND) according to individual profile in patients with prostate cancer (PCa) undergoing radical prostatectomy (RP), and to identify those who would benefit from the removal of the common iliac and pre-sacral nodes.
Patients and Methods
A total of 471 patients with high-risk PCa treated with RP and a super-extended PLND that included the removal of the presacral and common iliac nodes between 2006 and 2016 were identified. The risk of LNI was calculated according to the Briganti nomogram. Multivariable logistic regression analyses assessed the association between LNI risk and involvement of the common iliac and pre-sacral regions. The risk of positive common iliac and pre-sacral nodes was plotted over the LNI risk using the LOWESS-smoothed fit curve.
Results
The median preoperative LNI risk was 25.5%. The median number of nodes removed was 23, and 171 (36.3%) patients had LNI. Overall, 61 (13.0%) and 28 patients (5.9%), respectively, had positive common iliac and presacral nodes alone or in combination with other sites. The LNI risk was associated with the involvement of the common iliac and pre-sacral regions (all P < 0.001). The proportion of patients with positive common iliac and presacral nodes progressively increased according to the LNI risk. The adoption of a 30% threshold would result in avoiding the removal of the common iliac and pre-sacral nodes in >60% cases, with a risk of missing LNI in these regions of <5%.
Introduction
As a result of the relatively poor performance characteristics of both conventional and functional imaging in the identification of nodal metastases prior to radical prostatectomy (RP) [1] , an extended pelvic lymph node dissection (PLND) still represents the optimum method for nodal staging. According to the European Association of Urology and the National Comprehensive Cancer Network guidelines, an extended PLND should be performed in patients with prostate cancer (PCa) who are at higher risk of LNI based on preoperative characteristics (https://www.nccn. org/professionals/physician_gls/f_guidelines.asp) [2] [3] [4] .
Correct nodal staging would allow the identification of patients with LNI and the accurate assessment of the extent of nodal metastatic burden. This, in turn, is crucial for planning the optimum postoperative management of patients undergoing RP [5] [6] [7] .
Previous studies showed that an extended PLND that includes the removal of the external, internal iliac and obturator nodes would result in clearing~75% of all anatomical landing sites [8] . Adding the common iliac and pre-sacral regions to this template would further minimize the risk of missing positive lymph nodes [9] ; however, a more extended nodal dissection is typically associated with a higher risk of adverse peri-operative outcomes, such as prolonged operating time and complications [10, 11] . Accurate preoperative patient stratification is mandatory to identify individuals more likely to harbour metastases in the common iliac and pre-sacral nodes who should receive a dissection that includes these sites. The present study aimed to assess whether the preoperative LNI risk calculated according to the Briganti nomogram could be used to tailor the extent of PLND in high-risk patients. In particular, we evaluated the association between preoperative LNI risk and the site of nodal invasion in a contemporary cohort of high-risk patients who received a nodal dissection that included the common iliac and pre-sacral areas, in addition to the external iliac, obturator and hypogastric regions (namely, super-extended PLND).
Materials and Methods

Population Source and Surgical Procedure
After receiving institutional review board approval, we identified 9,344 patients treated with open or robot-assisted RP for localized PCa between January 2006 and July 2016 at a single tertiary referral centre. Only patients with complete preoperative and pathological data were considered (n = 6,630). Our analyses then focused exclusively on individuals with high-risk PCa (i.e. clinical stage T3 or higher and/or biopsy grade group 4-5 and/or preoperative PSA ≥20 ng/mL), who did not receive androgen deprivation therapy or radiotherapy before surgery. All patients received an anatomically defined super-extended PLND at the time of RP that included the removal of the obturator, internal iliac and external iliac lymph nodes, as well as the common iliac and pre-sacral nodes. This resulted in a final cohort of 471 patients.
Surgical Technique and Histopathological Evaluation
The fibrofatty tissue along the external iliac vein was dissected. The lateral limit was represented by the genitofemoral nerve and the distal limit was represented by deep circumflex vein and femoral canal [12] . Proximally, extended PLND included the removal of the common iliac lymph nodes up to aortic bifurcation. All fibrofatty tissue within the obturator fossa was removed to completely skeletonize the obturator nerve and the Marcille's triangular lumbosacral fossa was dissected free. Lymph nodes along, as well as medially and laterally to, the internal iliac vessels were then removed. Finally, the pre-sacral fossa was approached and the pre-sacral lymph nodes were removed. All cases were performed by six surgeons who applied the same anatomical template. Of all patients, 108 (22.9%) were treated with robot-assisted surgery, while the remaining 363 (77.1%) underwent open surgery. All specimens were submitted for pathological evaluation in multiple packages according to their anatomical location, and were evaluated by dedicated uro-pathologists, as previously described [3] .
Covariates and Endpoints
All patients were subjected to a detailed preoperative evaluation that consisted of PSA, clinical stage obtained according to the DRE performed by the attending urologist, and TRUS-guided prostate biopsy. Before surgery, all patients were staged with abdominopelvic contrast-enhanced CT and bone scans. The preoperative risk of LNI was calculated according to the Briganti nomogram [3] . All patients had complete data including pathological grade group, pathological stage, LNI, number of lymph nodes removed and number of positive nodes overall and stratified according to the anatomical location. The modified Gleason scoring system was adopted according to the International Society of Urological Pathology 2005 and 2014 consensus conferences [13, 14] .
Primary outcomes of the present study were represented by the number of positive nodes and by the involvement of the common iliac and pre-sacral regions. The secondary outcome was represented by postoperative complications, which were categorized according to the Clavien-Dindo classification system.
Statistical Analyses
Our statistical approach consisted of three main steps. First, multivariable linear regression analyses tested the association between preoperative risk of LNI and the number of positive nodes after adjusting for the number of nodes removed. Multivariable logistic regression analyses were used to assess the association between preoperative risk of LNI and the presence of positive lymph nodes in the common iliac and pre-sacral regions after adjusting for the number of nodes removed. Second, the number of positive lymph nodes and the estimated risk of positive common iliac and pre-sacral lymph nodes were plotted over the calculated risk of LNI using the LOWESS-smoothed fit curve. Finally, we performed a systematic analysis of the ability of different thresholds of the baseline risk of LNI calculated using the Briganti nomogram to discriminate between patients with or without involvement of the common iliac and pre-sacral lymph nodes. In particular, we categorized predicted probabilities of LNI into strata, and we evaluated how many patients with involvement of the common iliac and pre-sacral lymph nodes would be missed if these regions were not included in the extended PLND template after stratifying patients according to the different LNI risk thresholds.
All statistical tests were performed using the R statistical package v.3.0.2 (R Project for Statistical Computing, www.rproject.org). All tests were two-sided, with P values <0.05 taken to indicate statistical significance. Table 1 shows the clinical and pathological characteristics of patients included in our cohort. The median (interquartile range [IQR]) age at surgery was 66.7 (60.9-71.6) years. The median (IQR) preoperative risk of LNI calculated according to the Briganti nomogram was 25.5% (11.7-48.8%). None of the patients included in our cohort had enlarged pelvic lymph nodes at preoperative imaging. The median (IQR) number of lymph nodes removed was 23 (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . The median number of nodes removed did not vary according to the surgeon (P = 0.1). Although we observed a slight increase in the median number of nodes removed over the study period (21 vs 25 for the years 2006 vs 2016; respectively; P = 0.01), no statistically significant differences were observed in the median number of nodes removed between patients treated with open vs robot-assisted surgery (23 vs 23; P = 0.6). The median number of nodes removed in the common iliac and presacral stations was 6 and 4, respectively. Overall, 45 (9.5%), 103 (21.9%), 88 (18.6%), 56 (11.9%), and 179 (38.1%) patients harboured pathological grade group 1, 2, 3, 4 and 5 disease, respectively, and 185 (39.3%) and 171 (36.3%) patients had pathological stage ≥pT3b and LNI, respectively. Although the proportion of patients with positive nodes increased from 29% to 38% over the study period, the association between year of surgery and the risk of LNI was not confirmed after adjusting for pathological stage and pathological grade group (P = 0.7). The median (IQR) number of positive nodes was 3 (2-9). Positive obturator, external and internal iliac nodes, alone or in combination with involvement of other sites, were detected in 119 (25.3%), 102 (21.7%) and 56 (11.6%) patients, respectively. Moreover, in 61 (13.0%) and 28 patients (5.9%), positive common iliac and pre-sacral nodes were detected, alone or in combination (Fig. 1) . Overall, five patients (2.9%) with LNI had involvement of the common iliac or pre-sacral nodes in the absence of positive nodes in the obturator, external and internal iliac stations.
Multivariable linear regression analyses showed the baseline risk of LNI was significantly associated with the number of positive nodes after adjusting for the number of nodes removed (P < 0.001; Table 2 ). At multivariable logistic regression analyses, the baseline risk of LNI was significantly associated with the risk of involvement of the common iliac and pre-sacral lymph nodes (all P < 0.001).
Using the LOWESS method, a progressive increase in the number of positive lymph nodes according to the risk of LNI was observed (Fig. 2) . In particular, patients with a baseline risk of LNI <10% had a median number of positive nodes of 1. This increased to 2, 3 and 4 in those with a risk of LNI of ~30, 40 and 50%, respectively. Moreover, a progressive increase in the estimated risk of positive common iliac nodes according to the risk of LNI was observed (Fig. 3) . Similarly, the proportion of patients with involvement of the pre-sacral nodes progressively increased according to the baseline risk of LNI (Fig. 4) . Table 3 depicts a systematic analysis of the ability of different thresholds of the baseline risk of LNI to discriminate between patients with or without involvement of the common iliac and pre-sacral lymph nodes. In particular, we evaluated the proportion of patients with involvement of the common iliac and pre-sacral lymph nodes below different thresholds to estimate how many patients with LNI would be missed if these regions were not included in the PLND template. The adoption of a 30% threshold would result in avoiding the removal of the common iliac and pre-sacral lymph nodes in >60% of cases with a risk of missing LNI in these regions of <5%. By contrast, 26.4% and 13.5% of patients with a baseline risk of LNI ≥30% had nodal involvement in the common iliac and pre-sacral regions, respectively.
Overall, 105 patients (22.3%) experienced postoperative complications (Table 4) . When complications were stratified according to the Clavien-Dindo system, only 52 patients (11.0%) and one patient (0.2%), respectively, had grade III and IV complications. Overall, 43 patients (9.1%) experienced a pelvic lymphocele after surgery and 35 patients (7.4%) had a clinically significant lymphocele (i.e. a symptomatic lymphocele requiring treatment).
Discussion
An extended PLND that includes the removal of the external, internal iliac and obturator lymph nodes should be considered in patients with PCa at higher risk of LNI according to currently available guidelines (https://www.nccn. org/professionals/physician_gls/f_guidelines.asp) [2] . Although this template allows correct staging in >90% of patients who are at higher risk of nodal involvement, it would miss positive lymph nodes in~25% of patients [9] . The inclusion of the common iliac and pre-sacral nodal regions in the dissection template would minimize the number of patients with positive lymph nodes missed, while a complete excision would be obtained in~90% of patients [9] . Moreover, in mapping studies, the common iliac regions drain up to 22% of all sentinel nodes [15] [16] [17] ; however, a more extended PLND is associated with prolonged operating time and a higher incidence of adverse peri-operative outcomes [10, 18, 19] . As such, the identification of patients more likely to harbour metastases in the common iliac and pre-sacral nodes is crucial to select those who should receive a superextended PLND while sparing potential morbidities in patients less likely to have metastases in these sites. We hypothesized that currently available preoperative tools might predict the risk of having a higher nodal burden and, in turn, positive lymph nodes in the common iliac and pre-sacral regions; therefore, we tested the ability of the Briganti nomogram to identify men at higher risk of harbouring nodal metastases in these sites in a cohort of 471 patients with high-risk PCa who underwent a nodal dissection that included the common iliac and pre-sacral regions in addition to the standard, extended template [2, 8, 9] .
Several aspects of the present study deserve attention. First, the overall proportion of patients with positive lymph nodes in the common iliac and pre-sacral regions was 13% and 6%, respectively; however, <3% of patients with LNI had involvement of the common iliac or pre-sacral lymph nodes in the absence of metastases in other pelvic regions. These findings support the accuracy of a nodal dissection template that includes the external, internal iliac and obturator regions for the identification of LNI in patients with high-risk PCa; however, if the PLND were limited to these sites, some positive lymph nodes would have been left in situ in >10% of patients included in the present cohort. The accurate knowledge of nodal metastatic burden would have important implications for staging purposes and for the subsequent administration of postoperative therapies. Indeed, patients with low metastatic burden in the lymph nodes might experience excellent oncological control at long-term follow-up [20, 21] . Moreover, a proper nodal staging can better tailor the administration of postoperative therapies. Indeed, while patients with a low metastatic burden might be managed with initial observation or adjuvant radiotherapy according to the local extension of the disease, individuals with a higher nodal metastatic burden (i.e. more aggressive disease at the time of surgery) could benefit from the early administration of systemic therapies [5] [6] [7] . Finally, although a therapeutic role of extended PLND is still debated because of the lack of evidence from randomized controlled trials [10] , previous retrospective studies seemed to show a potential benefit of extended PLND in patients with more adverse pathological features [22] .
Second, we showed that the risk of LNI calculated using the Briganti nomogram, which is based on preoperative disease characteristics, independently predicts the probability of harbouring a higher number of positive lymph nodes and, therefore, of having a higher nodal metastatic burden. More importantly, we showed that the Briganti nomogram can be used to identify patients at higher risk of positive lymph nodes in the common iliac and pre-sacral areas. Although the probability of positive nodes in these sites increased according to the baseline LNI risk, the prevalence of positive common iliac and pre-sacral nodes exceeded 5% only when the risk of LNI was ≥30%. Given the prolonged operating time and increased risk of adverse peri-operative events associated with a more extended PLND [10, 19] , this preoperative tool can be used to identify men who should be considered for a dissection that includes the removal of the common iliac and pre-sacral lymph nodes (namely, super-extended PLND). In particular, in the present cohort, the adoption of a 30% threshold would spare this procedure and its potential morbidity to >60% of patients at the cost of missing positive nodes in the common iliac and pre-sacral regions in <5% of them. Nonetheless, it should be noted that the estimated risk of positive common iliac and pre-sacral nodes progressively increased according to the LNI risk even below the 30% threshold. By contrast, more than one out of four patients above the 30% threshold would have positive common iliac and/or pre-sacral lymph nodes. The identification of positive common iliac nodes could also guide the surgeon in the performance of an even more extended nodal dissection [23] .
From a clinical standpoint, the present findings suggest that the risk of LNI calculated according to the Briganti nomogram could be useful not only to identify patients who are candidates for an extended PLND at the time of RP, but could also to identify those patients more suitable for a super-extended, staging PLND.
The present study has some limitations. First, because of the lack of data on preoperative molecular imaging we were unable to compare the ability of the Briganti nomogram to novel imaging methods, such as prostate-specific membrane antigen positron-emisson tomography/CT scan. Nonetheless, their staging nodal accuracy in the preoperative setting is still suboptimal and, therefore, they are not recommended in clinical guidelines [1, 2] . In addition, we evaluated the Briganti nomogram in a cohort of patients at higher risk of LNI. As such, our results might not be generalizable when using different prediction tools or in other clinical settings [4] . In this light, an external validation of our model is needed prior to suggesting its application in the clinical practice. Second, all patients received a super-extended PLND that included the removal of the common iliac and pre-sacral nodes. We were unable, therefore, to assess the impact of the extension of nodal dissection on peri-operative outcomes. In this context, a more extended nodal dissection has been shown to be associated with a prolonged operating time and an increased risk of complications [10, 19] . Nonetheless, the rate of lymphoceles in the present cohort was similar to that reported by previous studies evaluating patients undergoing extended PLND [11, 24, 25] . Similarly, because all patients received a PLND that included the same template, we were unable to test the effect of a super-extended PLND on oncological outcomes. Third, the identification of LNI depends on the technique and experience of the pathologist. This might explain the slight increase in the number of nodes removed over the study period. Nonetheless, all patients received a super-extended PLND using the same anatomically defined template. Moreover, the lack of detailed data on the presence of intraductal carcinoma in our cohort prevented us from adjusting our analyses for this predictor of more aggressive disease [26] . Finally, because of the relatively short follow-up (median [IQR] 32; [27-36] months), we decided not to report oncological outcomes in our cohort of high-risk patients. Randomized controlled trials are still needed to address this issue. In conclusion, >10% of patients with high-risk PCa undergoing a super-extended PLND had positive common iliac and pre-sacral lymph nodes, alone or in combination with other anatomical pelvic regions. The risk of LNI calculated according to the Briganti nomogram was significantly associated with the probability of harbouring a higher number of positive nodes and of experiencing involvement of the common iliac and pre-sacral regions; however, <5% of patients with a risk of LNI <30% have positive common iliac and pre-sacral lymph nodes. A superextended staging PLND that includes these regions should then be considered exclusively in men with a risk of LNI ≥30% in order to spare its potential additional side effects in individuals at lower risk of harbouring metastases, while reducing the risk of under-staging men at higher risk of LNI.
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